Dr. Umer Najib, MD
Neurology (Neurology Physician)
92 Campus Dr Ste B
Scarborough, ME 04074
Who else practices at this address →
Cumberland County includes primary care (5% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 22
- In the NPI registry since
- 2011
- Medicare patients seen, 2024
- 112
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2011Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology Physician primary
ME license MD30541 · WV license 25946
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- West Virginia University Hospitals, Inc Morgantown, WV
Medical groups
- West Virginia University Medical Corporation (1,980 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 112
- Services billed
- 465
- Patients’ average age
- 69
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 41 | 31 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 33 | 21 |
| Established patient office or other outpatient visit, 20-29 minutes | 27 | 20 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 26 | 13 |
| New patient office or other outpatient visit, 45-59 minutes | 20 | 20 |
| New patient office or other outpatient visit, 60-74 minutes | 16 | 16 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 12 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Rizatriptan (rizatriptan benzoate) Other prescribers in Scarborough, ME | 48 |
| Nortriptyline Hcl Other prescribers in Scarborough, ME | 47 |
| Sumatriptan Succinate Other prescribers in Scarborough, ME | 37 |
| Topiramate Other prescribers in Scarborough, ME | 25 |
| Tizanidine Hcl Other prescribers in Scarborough, ME | 24 |
| Ubrelvy (ubrogepant) Other prescribers in Scarborough, ME | 22 |
| Amitriptyline Hcl Other prescribers in Scarborough, ME | 19 |
| Emgality Pen (galcanezumab-gnlm) Other prescribers in Scarborough, ME | 16 |
| Zonisamide Other prescribers in Scarborough, ME | 14 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Scarborough, ME | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 39 payments worth $30,717 in total to this clinician.
| AbbVie Inc. | $23,396 |
|---|---|
| Lundbeck LLC | $5,703 |
| Pfizer Inc. | $1,618 |
| Compensation for services other than consulting (speaking, faculty) | $22,263 |
|---|---|
| Consulting Fee | $7,075 |
| Food and Beverage | $924 |
| Travel and Lodging | $456 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $4,550 |
| Lundbeck LLC Sep 9, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $3,675 |
| AbbVie Inc. Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) UBRELVY · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) UBRELVY · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,250 |
| Pfizer Inc. Dec 12, 2025 | Consulting Fee NURTEC ODT · PAIN | $1,525 |
| AbbVie Inc. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $1,463 |
| Lundbeck LLC Sep 23, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $875 |
All 26 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Dec 12, 2025 | Consulting Fee NURTEC ODT · PAIN | $1,525 |
| AbbVie Inc. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $1,463 |
| Lundbeck LLC Sep 23, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $875 |
| AbbVie Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,250 |
| Lundbeck LLC Sep 9, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $3,675 |
| Lundbeck LLC Sep 9, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $67.55 |
| AbbVie Inc. Sep 9, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to OAKLAND, MD · in-kind | $65.80 |
| Lundbeck LLC Sep 9, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $29.16 |
| Lundbeck LLC Aug 23, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $383 |
| Lundbeck LLC Aug 23, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $50.00 |
| Lundbeck LLC Aug 23, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $50.00 |
| Lundbeck LLC Aug 23, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $30.00 |
| Lundbeck LLC Aug 23, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $15.00 |
| Lundbeck LLC Aug 22, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $204 |
| Lundbeck LLC Aug 22, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $125 |
| AbbVie Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $4,550 |
| AbbVie Inc. Aug 21, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to SAINT CLAIRSVILLE, OH · in-kind | $119 |
| AbbVie Inc. Aug 20, 2025 | Compensation for services other than consulting (speaking, faculty) UBRELVY · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Aug 20, 2025 | Travel and Lodging UBRELVY · NEUROSCIENCE · travel to CANONSBURG, PA · in-kind | $74.20 |
| Lundbeck LLC Aug 4, 2025 | Consulting Fee VYEPTI · NEUROLOGY | $46.00 |
| AbbVie Inc. Apr 18, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) UBRELVY · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Mar 27, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to CLARKSBURG, WV · in-kind | $56.00 |
| AbbVie Inc. Mar 11, 2025 | Compensation for services other than consulting (speaking, faculty) QULIPTA · NEUROSCIENCE | $3,250 |
| AbbVie Inc. Mar 6, 2025 | Travel and Lodging UBRELVY · NEUROSCIENCE · travel to CLARKSBURG, WV · in-kind | $60.20 |
| AbbVie Inc. Feb 20, 2025 | Travel and Lodging QULIPTA · NEUROSCIENCE · travel to CANONSBURG, PA · in-kind | $81.20 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 2 companies. The companies reported $18,038 in research payments for these studies, mostly to the institutions running them.
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
AbbVie Inc. · Active, not recruiting · NCT06417775 - Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine
AbbVie Inc. · Completed · NCT05216263 - M22-418 - Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine
AbbVie Inc. - M23-714 - Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
AbbVie Inc. - Preventive treatment of migraine: outcomes for patients in real-world healthcare systems (triumph)
Eli Lilly and Company
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.